Photons To Electrons

In 1839, French physicist Edmond Becquerel first noticed that under certain circumstances, sunlight shining on an electrode could create a weak electrical charge. Other scientists dabbled with this photovoltaic process, but it was not until 1954 that researchers at what was then Bell Laboratories in Holmdel, N.J., created a solar cell using crystalline silicon, the same substance used in computer chips. Solar research received a boost from the space program, which saw the conversion of sunlight

Written byTom Abate
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Simply put, the photovoltaic effect occurs when a photon strikes an electron, and knocks it out of orbit. The free electron leaves behind a positively charged "hole," thus producing a flow of current. The amount of sunlight that a given substance can convert into electricity is called its conversion efficiency. Many factors affect this efficiency rating. They include the amount of energy required to knock an electron from orbit, which is called the band gap; the atomic structure of the material, which can inhibit or aid the flow of electrons and holes once the photovoltaic process begins; the thickness of the material needed to absorb sunlight; the cost of making the material; and its ability to withstand wear and tear.

Photovoltaic researchers have spent the past decade refining the basic solar cell made of crystalline silicon, a substance that is conducive to the photovoltaic process because of its perfect atomic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies